Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Dual HER2 Suppression with Lapatinib plus Trastuzumab for Metastatic Inflammatory Breast Cancer: A Case Report of Prolonged Stable Disease.
Journal: Case reports in oncology
Published: October 03, 2018
Lorlatinib Salvages CNS Relapse in an ALK-Positive Non-Small-Cell Lung Cancer Patient Previously Treated With Crizotinib and High-Dose Brigatinib.
Journal: Clinical lung cancer
Published: July 26, 2018
Ribociclib plus letrozole versus letrozole alone in patients with de novo HR+, HER2- advanced breast cancer in the randomized MONALEESA-2 trial.
Journal: Breast cancer research and treatment
Published: September 15, 2017
Identification of early breast cancer patient cohorts who may benefit from lapatinib therapy.
Journal: European journal of cancer (Oxford, England : 1990)
Published: August 13, 2015
Patients with Slowly Proliferative Early Breast Cancer Have Low Five-Year Recurrence Rates in a Phase III Adjuvant Trial of Capecitabine.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 16, 2015
Long-term hazard of recurrence in HER2+ breast cancer patients untreated with anti-HER2 therapy.
Journal: Breast cancer research : BCR
Published: October 23, 2014
Health related quality of life of women in TEACH, a randomised placebo controlled adjuvant trial of lapatinib in early stage Human Epidermal Growth Factor Receptor (HER2) overexpressing breast cancer.
Journal: European journal of cancer (Oxford, England : 1990)
Published: August 28, 2014
Adjuvant docetaxel and cyclophosphamide plus trastuzumab in patients with HER2-amplified early stage breast cancer: a single-group, open-label, phase 2 study.
Journal: The Lancet. Oncology
Published: September 07, 2013
Eribulin mesylate versus ixabepilone in patients with metastatic breast cancer: a randomized Phase II study comparing the incidence of peripheral neuropathy.
Journal: Breast cancer research and treatment
Published: April 04, 2013
Pegylated liposomal doxorubicin plus carboplatin in patients with metastatic breast cancer: a phase II study.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: March 21, 2012
Showing 1-12 of 12
Last Updated: 09/26/2026